The synergistic effect of MUC1:E-selectin and MUC1:ICAM-1 may play an important role in breast cancer metastasis through the bloodstream where underglycosylated MUC1 can significantly slow the rolling velocity of CTCs thereby allowing for more frequent occurrence of firm adhesion events and subsequent extravasation. Here, MUC1 is linked to breast carcinoma.